3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone

Nenhuma marca registrada encontrada para este princípio ativo.

Não há notas sobre alimentos registradas para este princípio ativo.

• PropacetamolMODERADA

  A concentração sérica (nível no sangue) de Propacetamol pode aumentar quando usado junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The serum concentration of Propacetamol can be increased when it is combined with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• AcetaminophenMODERADA

  A concentração sérica (nível no sangue) de Acetaminophen pode aumentar quando usado junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The serum concentration of Acetaminophen can be increased when it is combined with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• VoriconazoleMODERADA

  A concentração sérica (nível no sangue) de 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone pode aumentar quando usado junto com Voriconazole.

  Visão para especialistas

  The serum concentration of 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone can be increased when it is combined with Voriconazole.

• 3,5-diiodothyropropionic acidLEVE

  A eficácia terapêutica de 3,5-diiodothyropropionic acid pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• 3,5-DiiodotyrosineLEVE

  A eficácia terapêutica de 3,5-Diiodotyrosine pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• BenzylthiouracilLEVE

  A eficácia terapêutica de Benzylthiouracil pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• DibromotyrosineLEVE

  A eficácia terapêutica de Dibromotyrosine pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• ElcatoninLEVE

  A eficácia terapêutica de Elcatonin pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of Elcatonin can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• MethylthiouracilLEVE

  A eficácia terapêutica de Methylthiouracil pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

• PalopegteriparatideLEVE

  A eficácia terapêutica de Palopegteriparatide pode diminuir quando usada junto com 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.

  Visão para especialistas

  The therapeutic efficacy of Palopegteriparatide can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.